GlobalData on MSN
CSA Medical submits application to FDA for RejuvenAir System
The system aims to address underlying chronic cough and issues with mucus production and clearance in chronic bronchitis.
CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of a Premarket Approval (PMA) application to the U.S. Food and Drug ...
Which virus promises to be the worst in years this January? Why is this virus spreading fast, and what can we do to protect ...
The final cough on Dr Asif's list is described as a chronic cough, which the GP says 'is the trickiest and most variable' as it can be a sign of underlying illnesses. These can include asthma, chronic ...
KAHR Bio (KAHR or the Company), a clinical-stage biotechnology company developing DSP107, a first-in-class, bispecific ...
Doctor Breaks Down the Real Risks of COPD in Pregnancy And 8 Ways to Reduce Them to Ensure a Healthy Baby Pregnancy already asks a lot of the body and when shortness of breath, wheezing or chronic ...
Misunderstanding COPD and asthma can be risky. Recognising the difference in the condition, treatment options, and the need for early intervention is important. Many people mix up asthma and chronic ...
The proportion of patients with postoperative pulmonary complications in the first 5 days after thoracic surgery did not ...
“Patients with pulmonary edema generally describe breathlessness. Sometimes they feel like they are suffocating or breathing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results